The US Food and Drug Administration (FDA) has approved Tryngolza (olezarsen) as an adjunct to diet to reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridaemia (sHTG), ie. TG ≥500 mg/dL.
Unless otherwise indicated, opinions expressed in the Triglyceride Education and Research Forum are those of the contributors. All patients should discuss their medication with their healthcare professional. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the Triglyceride Forum, co-chairs, steering committee, editorial advisory board, secretariat or grantors is accepted for the consequences of any misleading or inaccurate information.